Clinical Characteristics and Metabolic Predictors of Rapid Responders to Dipeptidyl Peptidase-4 Inhibitor as an Add-on Therapy to Sulfonylurea and Metformin.

Diabetes Metab J · 2015 · PMC4696985 · PMID 26616595

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

marginal significanceP =0.054so close (0.05 < p ≤ 0.1)

In the logistic regression, higher baseline HbA1c levels and shorter durations of diabetes were independent predictors for the rapid responders with the DPP4 inhibitor add-on, while male sex showed marginal significance ( P =0.054) ( Table 3 ).

also in 5,069 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.